Melanotan II LH

Melanotan II (MT-II) is a synthetic cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone (α-MSH), developed at the University of Arizona. Its cyclic lactam bridge structure (Ac-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-NH₂) provides enhanced metabolic stability compared to the linear endogenous α-MSH sequence.MT-II is a non-selective melanocortin receptor agonist with demonstrated binding affinity for MC1R, MC3R, MC4R, and MC5R subtypes. Laboratory research has investigated its role in melanogenesis activation through MC1R-mediated cAMP signaling, eumelanin production pathways, and melanocyte tyrosinase activity. Additional in-vitro studies have examined its interaction with MC3R/MC4R in hypothalamic cell models and its effects on energy homeostasis signaling.Molecular Weight: 1024.18 g/mol. Sequence: Ac-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-NH₂. Appearance: White lyophilized powder. Solubility: Soluble in water. Storage: -20°C, lyophilized, sealed and protected from light.